ST. LOUIS, Mo. and MOORESTOWN, N.J., May 03, 2018 -- Tabula Rasa HealthCare (NASDAQ:TRHC), a healthcare technology company offering comprehensive data-driven software solutions and services for healthcare organizations, today announced it has acquired Peak PACE Solutions, the leading health plan management solutions and services provider in the PACE (Program of All-inclusive Care for the Elderly) market. Peak PACE Solutions will become Peak Health Plan Management Services, and operate as a service of Capstone Performance Systems, a subsidiary of TRHC.
“Capstone’s mission is to help our client organizations succeed fiscally in a compliant manner,” said Capstone CEO Richard Schamp, MD. “We do this by delivering meaningful analysis to understand the complexities of Medicare risk adjustment, optimizing compliance and revenue. Having worked for years collaboratively with Peak, we look forward to integrating with Peak Health Plan Management Services and further enhancing TRHC value to PACE organizations.”
PACE is a federal program, with 250 centers located in 31 states serving a growing number of eligible Medicare and Medicaid participants. Peak performs back-office functions for PACE organizations, including acting as a Third Party Administrator (TPA) to manage claims from healthcare providers. The company is noted for its staff expertise in the PACE market, including several executive-level staff who previously worked in PACE organizations.
“We’re excited to have the opportunity to join the TRHC family and work alongside Capstone, which shares our commitment to the PACE market,” said Patty Bailey, CEO of Peak Health Plan Management Services. “Our services are complementary, and as one company we can offer a full range of solutions backed by our extensive experience in PACE.”
Peak PACE Solutions was founded in 2009 by David Reyes and Ronda Hackbart. Upon making the decision to retire, Reyes and Hackbart indicated their desire to sell Peak to a company familiar with and respectful of PACE. In addition to Capstone, TRHC’s CareKinesis provides pharmacy services to PACE plans across the country.
About Tabula Rasa HealthCare
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com. Follow us on Twitter @TabulaRasaHC for up-to-date information.
Forward-Looking Statements
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
Media Contact
Dianne Semingson
[email protected]
T: 215-870-0829
Investors
Bob East or Asher Dewhurst
Westwicke Partners
443-213-0500
[email protected]


GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
World game at war: why some European nations have threatened a World Cup boycott
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth
Same sparkle, different story: how lab-grown diamonds are transforming the market
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 



